Learn about the EMA
The European Medicines Agency (EMA) is a decentralised body of the European Union, located in London. Its main responsibility is the protection and promotion of public and animal health, through the evaluation and supervision of medicines for human and veterinary use (www.ema.europa.eu).
How we work with the CHMP
François Houÿez, EURORDIS Health Policy Director presents his experience of how patient groups work with the Committee for Human Medicinal Products at the European Medicines Agency...
Regulatory Procedures
Patrick Salmon Irish Medicines Board introduces the EURORDIS Summer School attendees to the Regulatory Procedures at the EMEA...
The European Medicines Agency (EMA)
Dr Juan Garcia Burgos from the EMA Medical Information Sector introduces the agency's work...
The Committee on Orphan Medicinal Products (COMP)
Yann le Cam CEO of EURORDIS introduces the Committee on Orphan Medicinal Products (COMP) at the European Medicine's Agency ...
The Paediatric Committee (PDCO)
Dr. Fernando de Andres gives a presenation entitles The regulation on pediatric medicines, a fresh approach to stimulate research on medicines for children: The Paediatric Committee: (PDCO)...
The Committee on Human Medicinal Products(CHMP)
Patrick Salmon Irish Medicines Board introduces the EURORDIS Summer School attendees to the Committee on Human Medicinal Products(CHMP) at the European Medicine's Agency ...
Scientific/Advice Protocol Assistance
Markku Toivonen Toivonen, MD, PhD Scientific Director NDA Regulatory Science Ltd...
Case Study 1: Patient involvement in EMA Protocol Assistance
A case study presenting the experience of Retina Europe's in participating in EMA Protocol Assistance...
Case Study 2: Patient involvement in EMA Protocol Assistance
A case study presenting the experience of the German Gaucher Association's participation in EMA Protocol Assistance...
Update of COMP activities (2010)
Jordi Linares, Head of Orphan Medicines at European Medicines Agency...
Patient involvement at the European Medicines Agency
François Houÿez, EURORDIS Health Policy Director...
Scientific Advice and Potocol Assistance: The Role of Patient Organisations
Dr. Josep Torrent-Farnell outlines how rare disease patient groups can work with the European Medicines Agency to participate in Protocol Assistance.
We comply with the HONcode standard for health trustworthy information
We are grateful for the financial support of the EURORDIS website by :
